Adriamycin-plasma membrane interaction in human erythrocytes.
A great body of data increasingly point to the cell membrane as an important target for adriamycin (ADR). However, the exact mechanism by which ADR exerts its cytotoxic action through the interaction with the plasma membrane is still unknown. In this study, the interaction of ADR with red blood cells from healthy donors was investigated by freeze-fracturing (FF) and scanning electron microscopy (SEM). The results obtained can be summarized as follows: a) a dose-dependent modification in the intramembrane particle (IMP) distribution was revealed by FF on both fracture faces of the plasma membrane of erythrocytes treated with 50 or 100 microM ADR; b) SEM observations allowed to reveal a discocyte-stomatocyte transition induced by 50 microM ADR and the formation of mottled cells at the higher dose; c) these morphological and ultrastructural changes were not related to lipid peroxidation as demonstrated by experiments with radical scavengers or strong oxidant substances; d) the analysis of IMP density seemed to rule out a segregation process of membrane proteins suggesting that ADR interacts with the plasma membrane by becoming incorporated within the lipid bilayer.
Arancia
G
G
Department of Ultrastructures, Istituto Superiore di Sanità, Rome, Italy.
Molinari
A
A
Crateri
P
P
Calcabrini
A
A
Silvestri
L
L
Isacchi
G
G
D004317:Doxorubicin / Q000378:metabolism* / Q000494:pharmacology; D004910:Erythrocyte Membrane / Q000032:analysis / Q000378:metabolism*; D004912:Erythrocytes / Q000187:drug effects; D005614:Freeze Fracturing; D006801:Humans; D008565:Membrane Proteins / Q000032:analysis; D008854:Microscopy, Electron / Q000379:methods; D008855:Microscopy, Electron, Scanning
D008565:Membrane Proteins; D004317:Doxorubicin